Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Details Narrative)

v3.19.3.a.u2
Stock-based Compensation (Details Narrative) - USD ($)
12 Months Ended
Dec. 23, 2019
Jun. 20, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Reverse stock split, description 1-for-7 reverse stock split        
Number of stock option granted     129,919 54,915  
Stock option contractual term     5 years 9 months 18 days 9 years 9 months 18 days  
Weighted average exercise price     $ 17.93 $ 20.45
Stock-based compensation expense     $ 510,478 $ 74,063  
Unrecognized compensation expense     $ 1,450,684    
Unvested stock options expected to be recognized over a weighted average period     5 years 9 months 25 days    
Minimum [Member]          
Fair value per share, weighted average     $ 9.88 $ 9.88  
Maximum [Member]          
Fair value per share, weighted average     $ 15.10 $ 15.10  
Non Qualified Stock Options [Member]          
Number of stock option granted       47,772  
Non Qualified Stock Options [Member] | Vested Option One [Member]          
Number of option purchase shares       45,200  
Options vesting period       4 years  
Non Qualified Stock Options [Member] | Vested Option Two [Member]          
Number of option purchase shares       2,572  
Options vesting period       1 year  
Employees [Member]          
Number of stock option granted   129,919      
Stock option contractual term   5 years      
Fair value per share, weighted average   $ 16.80      
Employees [Member] | Performance Shares [Member]          
Number of stock option granted   64,771      
Employees [Member] | Tranche One [Member] | Service Vesting [Member]          
Number of stock option granted   65,148      
Stock option contractual term   3 years      
Employees [Member] | Tranche One [Member] | In-license a new or additional drug [Member]          
Number of stock option granted   12,958      
Employees [Member] | Tranche Two [Member] | Phase 2a trial for PCS-499 Complete [Member]          
Number of stock option granted   12,958      
Employees [Member] | Tranche Three [Member] | Up-List From The OCTQB [Member]          
Number of stock option granted   38,855      
Employees and Non-Employees [Member]          
Number of stock option granted       54,915  
2019 Plan [Member]          
Number of shares available for issuance 500,000        
Reverse stock split, description one for seven reverse stock split        
2011 Plan [Member]          
Number of option purchase shares       7,143